Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Conversion of shares in Electrolux

According to AB Electrolux articles of association, owners of Series A shares are entitled to request that such shares are converted to Series B shares. Conversion reduces the total number of votes in the company.During September 2021, 41 Series A shares were at the request of shareholders converted to Series B shares, following which the total number of votes in the company amounts to 38,265,279. The total number of registered shares in the company amounts to 308,920,308 shares, of which 8,192,498 are Series A shares and 300,727,810 are Series B shares.

Metsä Tissue is planning a significant investment in a tissue mill in the UK

Metsä Tissue, the tissue paper business of the forest industry group Metsä Group, is planning to invest in a new tissue mill in the UK. The plan consists of 240 000 tons of tissue paper production capacity, built in several phases during the upcoming decade. The plans are part of the company’s Future Mill programme to drive world class environmental performance in tissue production. The production of the planned UK mill would be based on using sustainable fresh fibre pulp, and the first phase of the investment would be ready during 2025 to serve the professional and consumer tissue

David Tennant to play Alexander Litvinenko in NENT Group and ITV original drama

· Four-part series stars David Tennant (‘Doctor Who’; ‘Broadchurch’) and is scripted by George Kay (‘Lupin’; ‘Criminal’) · ‘Litvinenko’ to have Nordic, Baltic, Polish and Dutch premiere exclusively on NENT Group’s Viaplay streaming service · NENT Group to premiere at least 50 Viaplay Originals in 2021 Nordic Entertainment Group (NENT Group) and ITV have commissioned the four-part drama ‘Litvinenko’, starring David Tennant (‘Doctor Who’; ‘Broadchurch’) as Alexander Litvinenko, the former Russian Federal Security Services and KGB officer whose death in London from polonium poisoning

Evli and Fellow Finance have signed the merger and demerger plans based on the combination agreement announced on 14 July 2021

FELLOW FINANCE PLC COMPANY ANNOUNCEMENT 30.9.2021 AT 12:00 PMNOT FOR DISTRIBUTION IN OR INTO THE UNITED STATES, OR IN ANY OTHER JURISDICTION IN WHICH SUCH DISTRIBUTION WOULD BE PROHIBITED BY APPLICABLE LAW The Boards of Directors of Evli Bank Plc and Fellow Finance Plc have signed the merger and demerger plans based on the combination agreement announced on 14 July 2021 Evli Bank Plc ("Evli") has today signed the demerger plan based on the combination agreement announced by Evli and Fellow Finance Plc ("Fellow Finance") on 14 July 2021. In addition, Evli and Fellow Finance have today

Wematter launches Aurora TPU; increases flexibility in its material range

Swedish manufacturer Wematter is now expanding the materials portfolio for the Gravity 2021 SLS 3D printer with Aurora TPU, a rubber-like and durable material that can be used for a variety of applications in the medical technology and automotive industries, among others. Aurora TPU was developed in close cooperation with one of the company’s largest customers, which operates in the manufacturing of outdoor power products.Wematter is constantly developing its Gravity SLS 3D printer ecosystem to offer its customers more choices of additive manufacturing materials. As part of this initiative,

Nordea joins Catena’s MTN programme as new issuing institute

In May 2021, Catena established an MTN programme with a loan framework of SEK 5 billion. Today, Nordea Bank Abp joins the programme as an issuing institute.30 September 2021, 11.00 a.m. Swedbank is the lead bank for the MTN programme and already also acts as an issuing institute alongside Danske Bank and SEB. To date, Catena has issued securities for SEK 1.4 billion within the programme.“It is gratifying and positive to welcome Nordea to our MTN programme as an issuing institute and we look forward to working together on future issues,” comments David Silvesjö, CTO at Catena. Law

Composition of HKScan Corporation’s Shareholders’ Nomination Board

HKScan Corporation, Stock Exchange Release, 30 September 2021 at 12.00 a.m. Finnish timeComposition of HKScan Corporation’s Shareholders’ Nomination Board The largest shareholders of HKScan Corporation have, according to the charter of the shareholders’ nomination board, nominated the following persons as members of the nomination board: Veikko Kemppi, managing director, LSO Cooperative Per Lindahl, chairman of the board, Lantmännen ek. för. Hanna Kaskela, director, Responsible Investments, Varma Mutual Pension Insurance Company Furthermore, the board of directors of HKScan

Pihlajalinna Plc submitted a formal merger control notification to the Finnish Competition and Consumer Authority regarding the acquisition of Pohjola Sairaala

Pihlajalinna Plc                  Stock Exchange Release   30 September 2021 at 12.00 p.m. Pihlajalinna Plc submitted a formal merger control notification to the Finnish Competition and Consumer Authority regarding the acquisition of Pohjola Sairaala Pihlajalinna Plc announced on 2 July 2021 that Pihlajalinna Terveys Ltd, part of the Group, has agreed to acquire the entire stock of shares of Pohjola Hospital Ltd from its current owner Pohjola Insurance Ltd. The acquisition of the stock of shares is subject to a merger control clearance by the Finnish Competition and Consumer Authority

Herantis Pharma Announces Paper in Journal Genes on biomarker -driven approaches in Parkinson’s Disease

Herantis Pharma Plc, Press Release, 30 September 2021 at 12:00 EEST Herantis Pharma Plc (“Herantis”), focusing on disease-modifying therapies for debilitating neurodegenerative diseases, today announced that a review describing genetically targeted clinical trials in Parkinson’s disease has been published in Genes, a peer-reviewed open access journal of genetics and genomics. Precision medicine and focus on genetically defined subtypes of disease have been successful in oncology clinical trials in the past decade and similar approaches implementing genetics, biomarkers and smart clinical

Jakob Mörndal takes office as acting CEO of Castellum

The Board of Directors of Castellum has appointed Jakob Mörndal as acting CEO, to take office on 8 October. He succeeds Henrik Saxborn, who in April announced his departure from the company following more than eight years in the position.Jakob Mörndal most recently operated his own company and prior to this served as business development manager at Klövern, head of co-operative housing association activities at Stena Fastigheter and in high yield sales at Swedbank. “With Jakob Mörndal, Castellum will gain an acting CEO with solid experience of the property sector and investor market.

Vestas receives 63 MW order for two wind projects in the USA

News release from Vestas-American Wind TechnologyPortland, 30 September 2021Vestas has secured an order for two undisclosed wind projects in the U.S. totalling 63 MW. The order consists of 15 V117-4.2 MW turbines, with eight turbines at one project and seven turbines at the other project. For both projects, Vestas deliver supply and commissioning of the turbines, as well as a 20-year Active Output Management 5000 (AOM 5000) service agreement, designed to ensure optimised performance of the asset. Turbine deliveries for both projects is expected to begin in the third quarter of

Clavister Introduces Disruptive Subscription-based Pricing Model – Lowering Barriers to Innovative Cybersecurity Solutions

30 September 2021 – Örnsköldsvik, Sweden – Clavister , the European leader in high-performance cybersecurity solutions today announces the introduction of a new, innovative pricing model. Reflecting the company’s transition to a recurring revenue model focused on subscriptions, the development will enhance accessibility to Clavister’s latest cybersecurity technology. First empowering Next Generation Firewall and Secure SD-WAN solutions this will widen Clavister’s customer base, enabling Clavister

Remedy Entertainment Plc: Share subscriptions based on stock options 2018

Remedy Entertainment Plc                     Company release         30 September 2021 at 11:30 a.m. (EEST) Remedy Entertainment Plc: Share subscriptions based on stock options 2018          Between 1 June and 15 September 2021, a total of 226,300 Remedy Entertainment Plc’s new shares have been subscribed for with the company's stock options 2018. For subscriptions made with the stock options 2018, the entire subscription price of EUR 1,588,626.00 will be entered into the company’s reserve for invested unrestricted equity. Following the trade registration, the company’s total

Open doors for a deeper partnership

Kiiltonians regularly visit Pihla Group’s door factory, helping optimise adhesive-related processes and testing samples in climate chambers. The door factory’s production quality has improved even further since Kiilto’s service was introduced.Pihla Group is a window and door manufacturing company that is part of Inwido AB, the largest window and door manufacturer in Europe. Pihla Group’s Ruovesi door factory in Finland has relied on Kiilto adhesives for a long time. Over the last couple of years, the companies have further deepened their partnership. “We have switched to using a service

Digital Metal and Etteplan enter a Design Partnership in additive manufacturing

Etteplan, press release, 30 September 2021 at 10.15 CET Etteplan, a global engineering company and Digital Metal, a global leader in developing and manufacturing of high-precision metal binder jetting systems for industrial use, have agreed to enter into a strategic partnership in additive manufacturing. The partnership aims to offer design optimization solutions for Digital Metal binder jetting processes and to offer manufacturing companies the full benefit of the technology – from idea to complete component with volume production in mind. “Together with Etteplan we will be able

Audientes opens up for online pre-ordering in India and enters into cooperation agreement with eShopBox in India

Audientes announces today that it is now open for pre-ordering online in India and that it has entered into a collaboration with ecommerce fulfilment provider, eShopBox for the sale and fulfilment of Audientes’ self-fitting hearing aids on ecommerce channels in India, including Audientes.in and later Amazon.in and FlipKart.Consumers in India and elsewhere in the world can now pre-order Audientes’ hearing aid product, Ven™ for delivery in India. Audientes has entered into a partnership with eShopBox. This partnership makes it easy for Audientes to scale sales from multiple etail-platforms in

New number of votes in Bonava AB due to conversion

The number of votes in Bonava AB has changed due to conversions of 3,250 Class A shares to 3,250 Class B shares. The number of votes in the company hereby amounts to 210,180,660.According to Bonava’s articles of association, owner of a Class A share has the right to request that such share is converted to a Class B share. Each Class A share carries ten votes and each Class B share one vote. In September, a total of 3,250 Class A shares were converted to a total of 3,250 Class B shares at the request of shareholders. Following the conversions, there were, as of 30 September 2021, the last

Getinge invites to virtual Capital Markets Day on November 22, 2021

Getinge welcomes analysts, investors and media to participate at Getinge’s virtual Capital Markets Day on November 22, 2021.Getinge’s most recent Capital Markets Day was held in November 2018, when the Executive Team summarized the activities and priorities that would lead the company to its current position: strong customer focus, increased sales and profitability, as well as a strengthened financial position. Now, Getinge presents the next steps to strengthen the effects of the continuous improvement work and to take advantage of organic and acquisition related opportunities with

AlzeCure presents at Vator Healthcare Innovation Summit on October 7

AlzeCure Pharma AB (publ) (FN STO: ALZCUR), a pharmaceutical company that develops a broad portfolio of drug candidates for diseases affecting the central nervous system, with projects in both Alzheimer’s disease and pain, today announced that the company is participating at the Vator Healthcare Innovation Summit at Epicenter Stockholm on October 7 at 10:20 CEST, where CEO Martin Jönsson will present the company’s latest developments.The presentation will be live streamed and held in English. Register for the event at: https://vatorsecurities.se/event/vator-securities-healthcare-innovation-

Ahlstrom-Munksjö enhances FiltEV[®] portfolio for electric vehicles, delivering additional high performance solutions for cabin air and transmission filtration

AHLSTROM-MUNKSJÖ OYJ, PRESS RELEASE, SEPTEMBER 30, 2021 at 10:00 CEST Ahlstrom-Munksjö continues to focus on the growth segment of electrification, enhancing its latest product offering, totally dedicated to filtration media solutions for electric vehicles. The new solutions complement the products launched in May which included filtration solutions for cabin air, transmission and cooling systems.  Ahlstrom-Munksjö understands the market challenges and is developing new commercial solutions to address unmet customer needs for high performance filtration materials for electric vehicles.

Valmet to rebuild pretreatment system for RE Energy’s biorefinery in Denmark

Valmet Oyj’s trade press release on September 30, 2021 at 11:00 a.m. EETValmet will rebuild the pretreatment system for RE Energy’s biorefinery in Kalundborg, Denmark. The order was included in Valmet’s orders received of the second quarter 2021 and the delivery is planned for the first half of 2022. The value of the order will not be disclosed. “RE Energy acquired the old biorefinery with the clear intention to bring it back in operation. This includes replacing the pretreatment system to achieve stable operation. We have great expectations that we, through the corporation and with the

ExpreS2ion will participate in key investor and industry events in October 2021

ExpreS2ion Biotech Holding AB (“ExpreS2ion") will participate and hold presentations at key investor and industry events in October. These include events hosted by HC Andersen Capital as well as the World Vaccine Congress and BIO-EUROPE.To participate, please register or find more information via the links below. Additional information and updates can be found on the Meet Us  page of the ExpreS[2]ion website. HC Andersen Capital – Potential value of COVID-19 vaccine candidate (in Danish), October 14VirtualJoin CEO Bent Frandsen in taking a dive

There are no items matching the current filter
There are no more items matching the current filter
Back to top